Natural killer cell differentiation: Insights from knockout and transgenic mouse models and in vitro systems

Immunological Reviews

Volumn 165, Issue , 1998, Pages 47-61

  Williams, Noelle Sevilir ^a   Klem, Jennifer ^a,b   Puzanov, Igor J ^a,b   Sivakumar, P V ^a,b   Schatzle, John D ^a   Bennett, Michael ^a   Kumar, Vinay ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN RECEPTOR;

B LYMPHOCYTE; FLUORESCENCE ACTIVATED CELL SORTER; KNOCKOUT MOUSE; LYMPHOCYTE DIFFERENTIATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0031725321     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01229.x     Document Type: Review

References (131)

1. Ortaldo JR, Herberman RB. Heterogeneity of natural killer cells. Annu Rev Immunol 1984;2:359-394.
2. - cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. J Exp Med 1997;186:1609-1614.
3. Georgopoulos K, Moore DD, Derfler B. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 1992;258:808-812.
4. Wang J-H, et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 1996;5:537-549.
5. Wu L, Nichogiannopoulou A, Shortman K, Georgopoulos K. Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity 1997;7:483-492.
6. Georgopoulos K, et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 1994;79:143-156.
7. Georgopoulos K, Winandy S, Avitahl N. The role of the Ikaros gene in lymphocyte development and homeostasis. Annu Rev Immunol 1997;15:155-176.
8. Wang B, et al. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3ε gene. Proc Natl Acad Sci USA 1994;91:9402-9406.
9. Δ5/Δ5 mutant mice. Proc Natl Acad Sci USA 1995;92:7542-7549.
10. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997;91:661-672.
11. Galy A, Travis M, Cen D, Chen B. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 1995;3:459-473.
12. Martin FH, et al. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 1990;63:203-211.
13. Huang E, et al. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 1990;63:225-233.
14. Williams DE, et al. Identification of a ligand for the c-kit proto-oncogene. Cell 1990;63:167-174.
15. Lyman SD, et al. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 1993;75:1157-1167.
16. Hannum C, et al. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 1994;368:643-648.
17. Lyman SD, Jacobsen SEW c-kit ligand and flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 1998;91:1101-1134.
18. Matos ME, Schnier GS, Beecher MS, Ashman LK, Williams DE, Caligiuri MA. Expression of a functional c-kit receptor on a subset of natural killer cells. J Exp Med 1993;178:1079-1084.
19. bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand. Eur J Immunol 1997;27:354-360.
20. Carson WE, Haldar S, Baiocchi RA, Croce CM, Caligiuri MA. The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. Proc Natl Acad Sci USA 1994;81:7553-7557.
21. + NK progenitor. Blood 1994;9:2594-2601.
22. + hematopoietic progenitor cells. Blood 1995;85:3538-3546.
23. - functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J Exp Med 1996;184:1845-1856.
24. + hematopoietic progenitor cells. Blood 1996;87:2632-2640.
25. Cavazzana-Calvo M, et al. Role of IL-2, IL-7, and IL-15 in natural killer differentation from cord blood hematopoietic progenitor cells and from γc transduced severe combined immunodeficiency X1 bone marrow cells. Blood 1996;88:3901-3909.
26. 41, and W. EMBO J 1990;9:1805-1813.
27. d anemic mice. Exp Hematol 1981;9:691-696.
28. Hackett J Jr, Bennett M, Kumar V. Origin and differentiation of natural killer cells. I. characteristics of a transplantable NK cell precursor. J Immunol 1985;134:3731-3738.
29. J mutant. Cell 1991;64:1025-1035.
30. Meierhoff G, et al. Expression of flt3 receptor and flt3-ligand in human leukemia-lymphoma cell lines. Leukemia 1995;9:1368-1372.
31. + hematopoetic progenitor cells (HPCs) when combined with interleukin 15 (IL-15). Blood 1996;88:105b (Abstract).
32. McKenna HJ, et al. Targeted disruption of the flt3 ligand gene in mice affects multiple hematopoietic lineages, including natural killer cells, B lymphocytes, and dendritic cells. Blood 1996;88:474a (Abstract).
33. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 1995;3:147-161.
34. Chen K, et al. Antirumor activity and immunotherapeutic properties of flt3-ligand in a murine breast cancer model. Cancer Res 1997;57:3511-3516.
35. Lynch DH, Andreasen A, Maraskovsky E, Whitmore J, Miller RE, Schuh JCL. Flt3 ligand induces tumor regression and antitumor immune responses in vivo. Nat Med 1997;3:625-631.
36. Lee G, Namen AE, Gillis S, Ellingsworth LR, Kincade PW. Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-β. J Immunol 1989;142:3875-3883.
37. Murray R, Suda T, Wrighton N, Lee F, Zlotnik A. IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets. Int Immunol 1989;1:526-531.
38. Von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SEG, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995;181:1519-1526.
39. -/- mice. J Immunol 1996;157:2366-2373.
40. Peschon JJ, et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994;180:1955-1960.
41. + T cells, but not for natural killer cells. J Exp Med 1996;184:289-293.
42. Biron CA, Young HA, Kasaian MT. Interleukin 2-induced proliferation of murine natural killer cells in vivo. J Exp Med 1990;171:173-188.
43. Ishida Y, et al. Expansion of natural killer cells but not T cells in human interleukin 2/interleukin 2 receptor (Tac) transgenic mice. J Exp Med 1989;170:1103-1115.
44. Silva MRG, Hoffman R, Srour EF, Ascensao JL. Generation of human natural killer cells from immature progenitors does not require marrow stromal cells. Blood 1994;84:841-846.
45. - bone marrow progenitors. J Immunol 1993;150:5263-5269.
46. Kündig TM, Schorle H, Bachmann MF, Hengertner H, Zinkernagel RM, Horak I. Immune responses in interleukin-2-deficient mice. Science 1993;262:1059-1061.
47. DiSanto JP, Müller W, Guy-Grand D, Fischer A, Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc Natl Acad Sci USA 1995;92:377-381.
48. Cao X, et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 1995;2:223-238.
49. Noguchi M, et al. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993;73:147-157.
50. Park SY, et al. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 1995;3:771-782.
51. Nosaka T, et al. Defective lymphoid development in mice lacking Jak3. Science 1995;270:800-802.
52. Thomis DC, Gurniak CB, Tivol E, Shirpe AH, Berg LJ. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 1995;270:794-797.
53. Leonard WJ. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling. Annu Rev Med 1996;47:229-239.
54. Giri JG, Anderson DM, Kumaki S, Park LS, Grabstein KH, Cosman D. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J Leukoc Biol 1995;57:763-766.
55. Grabstein KH, et al. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 1994;264:965-968.
56. Giri JG, et al. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 1994;13:2822-2830.
57. Giri JG, et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J 1995;14:3654-3663.
58. Leclercq G, Debacker V, De Smedt M, Plum J. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. J Exp Med 1996;184:325-336.
59. Puzanov IJ, Bennett M, Kumar V. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J Immunol 1996;157:4282-4285.
60. Suzuki H, Duncan GS, Takimoto H, Mak TW. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor β chain. J Exp Med 1997;185:499-505.
61. Guy-Grand D, et al. Different use of T cell receptor transducing modules in two populations of gut intraepithelial lymphocytes are related to distinct pathways of T cell differentiation. J Exp Med 1994;180:673-679.
62. Duncan GS, Mittrücker H-W Kägi D, Matsuyama T, Mak TW. The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J Exp Med 1996;184:2043-2048.
63. Taki S, et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 1997;6:673-679.
64. Ogasawara K, et al. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 1998;391:700-703.
65. Bix M, Locksley RM. Natural T cells: cells that co-express NKRP-1 and TCR. J Immunol 1995;155:1020-1022.
66. Tanaka T, et al. A novel monoclonal antibody agains murine IL-2 receptor β-chain. Characterization of receptor expression in normal lymphoid cells and El-4 cells. J Immunol 1991;147:2222-2230.
67. + T cells: a new family of T cells. Immunol Today 1996;17:71-76.
68. - single-positive thymocyte subpopulation that expresses a highly skewed T cell antigen receptor family. Proc Natl Acad Sci USA 1992;89:6506-6510.
69. - T cells in mice and humans. J Exp Med 1994;180:1097-1106.
70. + T cells promptly produced IL-4 in response to in vivo challenge with anti-CD3. J Exp Med 1994;179:1285-1295.
71. + thymocytes selected by MHC class I molecules. Science 1994;263:1174-1178.
72. + T lymphocytes. Science 1995;268:863-865.
73. Boesteanu A, De Silva AD, Nakajima H, Leonard WJ, Peschon JJ, Joyce S. Distinct roles for signals relayed through the common cytokine receptor γ chain and interleukin 7 receptor α chain in natural T cell development. J Exp Med 1997;186:331-336.
74. - murine thymocytes positively selected by class I molecules. J Exp Med 1994;180:653-661.
75. Lantz O, Sharara LI, Tilloy F, Andersson A, DiSanto JP. Lineage relationships and differentiation of natural killer (NK) T cells: intrathymic selection and interleukin (IL)-4 production in the absence of NKR-P1 and Ly49 molecules. J Exp Med 1997;185:1395-1401.
76. + cell development. J Immunol 1997;159:5931-5935.
77. Trinchieri G, Santoli D, Koprowski H. Spontaneous cell-mediated cytotoxicity in humans: role of interferon and immunoglobulins. J Immunol 1978;120:1849-1855.
78. Nunn ME, Heberman RB, Holden HT. Natural cell-mediated cytotoxicity in mice against non-lymphoid tumor cells and normal cells. Int J Cancer 1977;20:381-387.
79. Ljunggren HG, Kärre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11:237-244.
80. Colonna M, Samaridis J. Cloning of Ig-superfamily members associated with HLA-C and HLA-B recognition by human NK cells. Science 1995;268:405-408.
81. Wagtmann N, et al. Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995;2:439-449.
82. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL. Molecular cloning of NKB1: a natural killer cell receptor for HLA-B allotypes. J Immunol 1995;155:2306-2310.
83. Chan P-Y, Takei F. Molecular cloning and characterization of a novel murine T cell surface antigen, YE1/48. J Immunol 1989;142:1727-1736.
84. Smith HR, Karlhofer RM, Yokoyama WM. Ly-49 multigene family expressed by IL-2-activated NK cells. J Immunol 1994;153:1068-1079.
85. Binstadt BA, Brumbaugh KM, Leibson PJ. Signal transduction by human NK cell MHC-recognizing receptors. Immunol Rev 1997;155:197-203.
86. Ryan JC, Seaman WM. Divergent functions of lectin-like receptors on NK cells. Immunol Rev 1997;155:79-89.
87. Nakamura MC, Niemi EC, Fisher MJ, Shultz LD, Seaman WE, Ryan JC. Mouse Ly49A interrupts early signaling events in NK cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J Exp Med 1997;185:673-684.
88. Leibson PJ. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 1997;6:655-661.
89. Djeu JY, Stocks N, Zoon K, Stanton GJ, Timonen T, Herberman RB. Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses. J Exp Med 1982;156:1222-1234.
90. Weigent DA, Stanton GJ, Johnson HM. Interleukin 2 enhances natural killer cell activity through induction of γ interferon. Infect Immun 1983;41:992-997.
91. Trinichieri G. Interleukin-12: a proinflamatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-276.
92. Okamura H, et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 1995;378:88-91.
93. Ushio S, et al. Cloning of the cDNA for human IFN-γ inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 1996;156:4274-4279.
94. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 1993;259:1739-1742.
95. Magram J, et al. IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses. Immunity 1996;4:471-481.
96. Takeda K, et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998;8:383-390.
97. Bacon CM, et al. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci USA 1995;92:7307-7311.
98. Jacobson NG, et al. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J Exp Med 1995;181:1755-1762.
99. Kaplan MH, Sun Y-A, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 1996;382:174-177.
100. Thierfelder WE, et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 1996;382:171-173.
101. Perussia B, et al. Murine natural killer cells express functional Fcγ receptor II encoded by the FcγRα gene. J Exp Med 1989;170:73-86.
102. Ravetch JV, Kinet J-P. Fc receptors. Annu Rev Immunol 1991;9:457-192.
103. Rodewald HR, Moingeon P, Lucich JL, Dosiou C, Lopez P, Reinherz EL. A population of early fetal thymocytes expressing FcγRII/III contains precursors of T lymphocytes and natural killer cells. Cell 1992;69:139-150.
104. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV. FcRγ chain deletion results in pleiotrophic effector cell defects. Cell 1994;76:519-529.
105. + T cells. J Exp Med 1997;186:1957-1963.
106. + T and natural killer cell precursors in FcεRIγ transgenic mice. J Exp Med 1996;184:1725-1735.
107. Hasui M, et al. Effector and precursor phenotypes of lymphokine-activated killer cells in mice with severe combined immunodeficiency (scid) and athymic (nude) mice. Cell Immunol 1989;120:230-239.
108. Godfrey DI, Masciantonio M, Tucek CL, Malin MA, Boyd RL, Hugo P. Thymic shared antigen-1. A novel thymocyte marker discriminating immature from mature thymocyte subsets. J Immunol 1992;148:2006-2011.
109. Antica M, Wu L, Shortman K, Scollay R. Thymic stem cells in mouse bone marrow. Blood 1994;84:111-117.
110. Moore TA, Zlotnik A. T-cell lineage commitment and cytokine responses of thymic progenitors. Blood 1995;86:1850-1860.
111. Lisovsky M, et al. Flt3-ligand production by human bone marrow stromal cells. Leukemia 1996;10:1012-1018.
112. Jacobsen SE, Okkenhaug C, Mykleburst J, Veiby OP, Lyman SD. The flt3 hgand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL)-11, IL-12, and other hematopoietic growth factors. J Exp Med 1995;181:1358-1363.
113. + cells. Blood 1997;90:3903-3913.
114. Williams NS, et al. Natural killer cell differentiation: receptor functions and repertoire. In: R. B. Herberman, W. H. Chambers, eds. NK cells and cancer: biology and therapy. Totowa (NJ): Humana Press (In press).
115. Garni-Wagner BA, Purohit A, Mathew PA, Bennett M, Kumar V. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol 1993;151:60-70.
116. + IL-2 activated natural killer cells. Nature 1992;358:66-70.
117. Takei F, Brennan J, Mager DL. The Ly-49 family: genes, proteins and recognition of class I MHC. Immunol Rev 1997;155:67-77.
118. Höglund P, et al. Host MHC class I gene control of NK-cell specificity in the mouse. Immunol Rev 1997;155:11-28.
119. Raulet DH, Held W, Correa I, Dorfman JR, Wu M-F, Corral L. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 1997;155:41-52.
120. - cells can distinguish the presence and absence of class I on target cells - evidence for a Ly-49-independent negative signaling receptor. Eur J Immunol 1998;27:3100-3104.
121. Chang C, Rodriguez A, Carretero M, López-Botet M, Phillips J, Lanier LL. Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 1995;25:2433-2437.
122. Houchins JP, Yabe T, McSherry C, Bach FH. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 1991;173:1017-1020.
123. Lazetic S, Ching C, Houchins JP, Lanier LL, Phillips JH. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 1996;157:4741-4745.
124. Brooks AG, Posch PE, Scorzelli CJ, Borrego F, Coligan JE. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J Exp Med 1997;185:795-800.
125. Carretero M, et al. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol 1997;27:563-567.
126. Brumbaugh KM, Perez-Villar JJ, Dick CJ, Schoon RA, López-Botet M, Leibson PJ. Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses. J Immunol 1996;157:2804-2812.
127. López-Botet M, et al. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immunol Rev 1997;155:165-174.
128. Phillips JH, Chang C, Mattson J, Gumperz JE, Parham P, Lanier LL. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 1996;5:163-172.
129. Sivori S, et al. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur J Immunol 1996;26:2487-2492.
130. Braud VM, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B, and C. Nature 1998;391:795-799.
131. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 1998;187:813-818.